News
FDA clears first drug for MCT8 deficiency
Sweden's Egetis has won approval in the US for the first-ever treatment for people living with the ultra-rare genetic disease MCT8 deficiency.
Sales & Marketing
Sponsored
Commercial Evidence: Turning field intelligence into actiona...
Agentic Call Reports help turn field observations into scalable, actionable insights generating Commercial Evidence.
News
MSD takes a $400m bite of SciBrunch's KRAS drug
MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
News
AbbVie's Cerevel takeover delivers Parkinson's approval
The first drug from AbbVie's $8.7 billion takeover of Cerevel two years ago, Parkinson's disease therapy Juvmo, has won FDA approval.
News
MSD, Daiichi pull filing for lung cancer candidate I-DXd
MSD and Daiichi Sankyo's regulatory efforts for their ADCs for cancer have stuttered again, with a withdrawn filing for lung cancer candidate I-DXd.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
